All Timely Result Earnings PR IR Governance ASR Shareholders' meeting Notice R&D Recruit Recipe Release Others

• 2024/08/29 Notice Regarding Change in Personnel of the General Manager （84KB）

• 2024/08/09 Consolidated Financial Results for the Three Months Ended June 30, 2024 （251KB）

• 2024/08/09 Summary of Financial Results for the first quarter 2025 （24KB）

• 2024/08/07 Notice Regarding Completion of Payment Procedures for Disposal of Treasury Stock as Restricted Share-based Remuneration （110KB）

• 2024/07/29 Notice Regarding Disposal of Treasury Stock as Restricted Share-based Remuneration （95KB）

• 2024/06/27 Notice Regarding Change in Personnel of the General Manager （86KB）

• 2024/06/03 Notice of the 85th Annual General Meeting of Shareholders （162KB）

• 2024/05/24 Notice Regarding Change in Representative Director （54KB）

• 2024/05/15 Annoucemnet of 2024ｰ2026 Medium-Term Management Plan （993KB）

• 2024/05/15 Notice Regarding the Recording of Non-operating Income (Consolidated/Non-consolidated) and Extraordinary Losses (Consolidated/Non-consolidated), Differences between the Full Year Consolidated Financial Results Forecast and Actual Results for Fiscal 2024, and Differences between Non-consolidated Financial Results for Fiscal 2024 and Fiscal 2023 （165KB）

• 2024/05/15 Temporary Suspension of Production Facility Operations at Consolidated Subsidiary in India (Progress of Previously Disclosed Matter) （124KB）

• 2024/05/15 Financial Results Presentation for the Year Ended March 31, 2024 （275KB）

• 2024/05/15 Consolidated Financial Results for the Fiscal Year Ended March 31, 2024 （366KB）

• 2024/05/15 Summary of Financial Results 2024 （27KB）

• 2024/05/14 Notice of Postponement of Disclosure of Financial Results for the Fiscal Year Ending March 2024 （57KB）

• 2024/04/26 Notice Regarding Changes in Directors and Audit & Supervisory Board Members （154KB）

• 2024/04/26 Notice Regarding Officer Remuneration （131KB）

• 2024/03/21 Notice Regarding Changes in Organization and Personnel Such as Directors, Executive Officers and General Managers （230KB）

• 2024/03/21 Notice Regarding Changes in Directors （220KB）

• 2024/03/21 Notice Regarding Change in Representative Director （218KB）

• 2024/03/21 Temporary Suspension of Production Facility Operations at Consolidated Subsidiary in India （155KB）

• 2024/03/19 Announcement of the Release of "Web Institute" in Chinese Website

  読む Announcement of the Release of "Web Institute" in Chinese Website

• 2024/02/13 Discontinuation of Production at a Consolidated Subsidiary and Revisions to the Full-Year Forecast of Financial Results for the Fiscal Year Ending March 31, 2024 （403KB）

• 2024/02/13 Notice Regarding Impairment Loss (Consolidated), Loss on Valuation of Shares of Subsidiaries and Associates (Non consolidated), and Revision of the Full Year Business Forecasts （115KB）

• 2024/02/13 Consolidated Financial Results for the Nine Months Ended December 31, 2023 （279KB）

• 2024/02/13 Summary of Financial Results for the third quarter 2024 （23KB）

• 2024/01/25 Notice Regarding Discontinuation of Production at a Consolidated Subsidiary （121KB）

• 2023/12/26 Announcing the Launch of New Chinese Website

  読む Announcing the Launch of New Chinese Website

• 2023/11/13 Notice of Differences between Forecast and Actual Consolidated Financial Results for the First Half of FY2024 （108KB）

• 2023/11/13 Consolidated Financial Results for the Six Months Ended September 30, 2023 （283KB）

• 2023/11/13 Summary of Financial Results for the second quarter 2024 （24KB）

• 2023/10/19 Notice Regarding Changes in an Executive Officer and a General Manager （114KB）

• 2023/09/21 Notice Regarding Resignation of a Member of the Board of Directors （93KB）

• 2023/09/07 Notice Regarding Changes in the Executive Officers （121KB）

• 2023/08/24 Notice Regarding Change in the Executive Officer and the General Manager （113KB）

• 2023/08/10 Consolidated Financial Results for the Three Months Ended June 30, 2023 （286KB）

• 2023/08/10 Summary of Financial Results for the first quarter 2024 （28KB）

• 2023/06/19 Notice Regarding Change in Personnel of the General Manager （106KB）

• 2023/06/19 Progress Report (Changes) of the Plan for Compliance with the Prime Market’s Continued Listing Criteria as Well as Decision to Apply for the Standard Market and Status of Compliance （219KB）

• 2023/06/13 Notice of the 84th Annual General Meeting of Shareholders （171KB）

• 2023/05/24 Notice Regarding Changes in Position of Board Members and Audit & Supervisory Board Member （118KB）

• 2023/05/12 Notice Regarding Recognition of Non-Operating Income, Extraordinary Gains, and Extraordinary Losses, as well as Differences between Non-Consolidated Financial Results and Previous Fiscal Year’s Results （129KB）

• 2023/05/12 Consolidated Financial Results for the Fiscal Year Ended March 31, 2023 （416KB）

• 2023/05/12 Summary of Financial Results 2023 （28KB）

• 2023/03/07 Notice Regarding Changes in Organization and Personnel Such as Board Members, Executive Officers and the General Managers （108KB）

• 2023/02/13 Notice Regarding Progress of Plan for Compliance with Continued Listing Criteria （166KB）

• 2023/02/13 Consolidated Financial Results for the Nine Months Ended December 31, 2022 （269KB）

• 2023/02/13 Summary of Financial Results for the third quarter 2023 （27KB）

• 2022/12/22 Notice Regarding Change in Position of Executive Officer （91KB）

• 2022/11/14 Notice Regarding Differences between Forecast and Actual Consolidated Financial Results for the First Half of FY2023, Revisions to Full-Year Forecast of Consolidated Financial Results and Revisions to Dividend Forecast （142KB）

• 2022/11/14 Consolidated Financial Results for the Six Months Ended September 30, 2022 （291KB）

• 2022/11/14 Summary of Financial Results for the second quarter 2023 （17KB）

• 2022/09/08 Announcement of Analyst Report Release by Shared Research Inc （54KB）

• 2022/08/09 Consolidated Financial Results for the Three Months Ended June 30, 2022 （280KB）

• 2022/08/09 Summary of Financial Results for the first quarter 2023 （379KB）

• 2022/07/21 Notice Regarding the Disposal of Treasury Stock as Restricted Share-based Remuneration （136KB）

• 2022/06/28 Notice Regarding Change in Position of Board Member and Personnel Change in General Manager Level （101KB）

• 2022/06/08 Business Strategy （2,477KB）

• 2022/05/25 Notice Regarding Amendment to the Articles of Incorporation （158KB）

• 2022/05/13 Notice Regarding Recognition of Non-Operating Income and Differences between Non-Consolidated Financial Results and Previous Fiscal Year’s Results （179KB）

• 2022/05/13 Consolidated Financial Results for the Fiscal Year Ended March 31, 2022 （844KB）

• 2022/05/13 Summary of Financial Results 2022 （29KB）

• 2022/04/21 Notice Regarding Changes in Personnel Such as Board Members and Executive Officers （133KB）

• 2022/04/04 The sustainability site has been released.

• 2022/02/24 Notice Regarding Changes in Organization and Personnel Such as Executive Officers and the General Manager Level （117KB）

• 2022/02/14 Consolidated Financial Results for the Nine Months Ended December 31, 2021 （282KB）

• 2022/02/14 Summary of Financial Results for the third quarter 2022 （24KB）

• 2021/12/16 Plan for Conformance with the Continued-Listing Criteria for the New Market Segments （1,113KB）

• 2021/11/12 Consolidated Financial Results for Six Months Ended September 30, 2021 （396KB）

• 2021/11/12 Summary of Financial Results for the second quarter 2022 （129KB）

• 2021/10/21 Notice Regarding Changes in Personnel （97KB）

• 2021/08/10 Consolidated Financial Results for the Three Months Ended June 30, 2021 （294KB）

• 2021/08/10 Summary of Financial Results for the first quarter 2022 （362KB）

• 2021/07/15 Notice Regarding the Disposal of Treasury Stock as Restricted Share-based Remuneration （136KB）

• 2021/06/29 Notice Regarding Change in Position of Board Member and Personnel Change in General Manager Level （102KB）

• 2021/05/13 Nitta Gelatin Announces Medium-Term Management Plan （596KB）

• 2021/05/13 Notice regarding Differences between Non-consolidated Financial Results and Previous Fiscal Year’s Results （162KB）

• 2021/05/13 Consolidated Financial Results for the Fiscal Year Ended March 31, 2021 （720KB）

• 2021/05/13 Summary of Financial Results 2021 （113KB）

• 2021/02/12 Notice Regarding Changes in Organization and Personnel Such as Board Members and Executive Officers （112KB）

• 2021/02/12 Consolidated Financial Results for the Nine Months Ended December 31, 2020 （424KB）

• 2021/02/12 Summary of Financial Results for the third quarter 2021 （115KB）

• 2021/01/21 Notice Regarding Changes in Shareholder Benefit Program （101KB）

• 2021/01/21 Notice Regarding Changes in Organization and Personnel Such as Executive Officers and the General Manager Level （115KB）

• 2020/12/17 Notice Concerning Board of Directors Resolution regarding the Company Split (Simplified Absorption-Type Split) of the Adhesive Business (Manufacturing) with Bostik-Nitta Co., Ltd. （262KB）

• 2020/11/19 Notice Concerning Absorption-Type Merger with Wholly-Owned Subsidiary (Simplified Merger and Short-Form Merger) （143KB）

• 2020/11/11 Consolidated Financial Results for the Six Months Ended September 30, 2020 （356KB）

• 2020/11/11 Summary of Financial Results for the second quarter 2021 （121KB）

• 2020/10/29 Notice Concerning Postponement of the Company Split (Simplified Absorption-Type Split) of the Adhesive Business (Manufacturing) with Bostik-Nitta Co., Ltd. （110KB）

• 2020/09/17 Notice Concerning Board of Directors Resolution regarding the Company Split (Simplified Absorption-Type Split) of the Adhesive Business (Manufacturing) with Bostik-Nitta Co., Ltd. （310KB）

• 2020/09/17 Notice of Biomedical Site Renewal

  読む Notice of Biomedical Site Renewal

• 2020/08/07 Consolidated Financial Results for the Three Months Ended June 30, 2030 （338KB）

• 2020/08/07 Summary of Financial Results for the first quarter 2021 （88KB）

• 2020/06/25 Notice Regarding the Date, Time, Etc. for Holding a Follow-up Meeting for the 81st Ordinary General Shareholders’ Meeting （165KB）

• 2020/06/24 Notice Regarding Differences Between Non-consolidated Financial Results and Previous Fiscal Year’s Results （196KB）

• 2020/06/24 Consolidated Financial Results for the Fiscal Year Ended March 31, 2020 （654KB）

• 2020/06/24 Summary of Financial Results 2020 （150KB）

• 2020/06/09 Notice Regarding Announcement of Consolidated Financial Results for the Fiscal Year Ended March 31, 2020 （111KB）

• 2020/06/03 Notice Regarding the Results and Completion of Purchase of Treasury Stock （100KB）

• 2020/05/22 Notice Regarding Policy for Holding a Follow-up Meeting for the 81st Ordinary General Shareholders’ Meeting （201KB）

• 2020/05/22 Notice Regarding Dividends of Surplus （126KB）

• 2020/05/07 Notice Regarding the Results of Purchase of Treasury Stock （104KB）

• 2020/04/23 Notice Regarding Postponement of Announcement of Consolidated Financial Results for the Fiscal Year Ended March 31, 2020 （108KB）

• 2020/03/27 Notice Regarding Decision on Item related to Purchase of Treasury Stock （101KB）

• 2020/02/20 Notice Regarding Changes in Organization and Personnel Such as Board Members, Executive Officers and the General Manager Level （134KB）

• 2020/02/17 A paper about the clinical trial resulting in an improvement of Type II Diabetes by collagen peptide were published in Journal of Diabetes & Metabolism

• 2020/02/10 Notice Concerning Revision of Consolidated Business Forecasts （60KB）

• 2020/02/10 Consolidated Financial Results for the Nine Months Ended December 31, 2019 （383KB）

• 2020/02/10 Summary of Financial Results for the third quarter 2020 （122KB）

• 2020/01/10 A paper about the presence of Pro-Hyp and Hyp-Gly in fetal bovine serum and the effects of these peptides on fibroblasts has been published

• 2019/12/25 A pilot clinical study outcome which indicates effects of collagen hydrolysates on human brain structure and cognitive function was published in Nutrients.

• 2019/12/19 Notice Regarding Changes at Specified Subsidiary and Subsidiary （226KB）

• 2019/12/12 Notice Regarding Transfer of Shares at Specified Subsidiary and Equity-Method Affiliate (Progress Report on Disclosed Matters) （20KB）

• 2019/12/11 The report for “Collagen Peptide Symposium” and a Roundtable Discussion at an International Conference about functional foods

  読む The report for “Collagen Peptide Symposium” and a Roundtable Discussion at an International Conference about functional foods

• 2019/11/21 Notice Regarding Change of Expected Date for Changes (Transfer of Shares) and Amount of Transfer at Specified Subsidiary and Equity-Method Affiliate （91KB）

• 2019/11/08 Notice Concerning Differences between Consolidated Financial Forecasts and Actual Results for the Six Months Ended September 30, 2019 （34KB）

• 2019/11/08 Consolidated Financial Results for the Six Months Ended September 30, 2019 （385KB）

• 2019/11/08 Summary of Financial Results for the second quarter 2020 （108KB）

• 2019/10/08 A clinical trial paper on the efficacy of Collagen Peptides for healthy subjects knee joint was published in Jpn Pharmacol Ther

  読む A clinical trial paper on the efficacy of Collagen Peptides for healthy subjects knee joint was published in Jpn Pharmacol Ther

• 2019/10/08 In joint studies with Josai University, bone quality improvement mechanism of collagen-derived peptide Pro-Hyp was published in Biosci Biotechnol Biochem.

• 2019/10/02 Notice Regarding Further Postponement of Expected Date for Changes (Transfer of Shares) at Specified Subsidiary and Equity-Method Affiliate （101KB）

• 2019/08/26 Notice of posting corporate profile

  読む Notice of posting corporate profile

• 2019/08/08 Consolidated Financial Results for the Three Months Ended June 30, 2019 （356KB）

• 2019/08/08 Summary of Financial Results for the first quarter 2020 （131KB）

• 2019/07/02 Notice Regarding Postponement of Expected Date for Transfer of Shares for Specified Subsidiary and Equity-Method Affiliate （113KB）

• 2019/06/13 Notice Regarding Company Name Change for a Nitta Gelatin Consolidated Subsidiary （103KB）

• 2019/05/14 Notice Concerning Recording of Non-Operating Income and Extraordinary Gains/Losses, and Differences between Full-Year Consolidated Financial Forecasts and Results, and Differences between Non-consolidated Financial Results and Previous Fiscal Year’s Results （200KB）

• 2019/05/14 Consolidated Financial Results for the Fiscal Year Ended March 31, 2019 （722KB）

• 2019/05/14 Summary of Financial Results 2019 （274KB）

• 2019/04/25 Notice Regarding Change in Appointment of Board Members and Executive Officers （142KB）

• 2019/03/19 Notice Regarding the Decided Transfer Cost for Specified Subsidiary and Equity-Method Affiliate (Progress Report on Disclosed Matters) （109KB）

• 2019/02/22 Notice Regarding Change in Organization and Personnel （114KB）

• 2019/02/21 Notice Regarding Changes at Specified Subsidiary and Equity-Method Affiliate （205KB）

• 2019/02/08 Notice Concerning Recording of Non-Operating Expenses (Equity in Losses of Affiliates) and Revision of Full-Year Consolidated Financial Forecasts and Year-End Dividend Forecast (Commemorative Dividend for 100th Anniversary of Foundation) for the Fiscal Year Ending March 31, 2019 （225KB）

• 2019/02/08 Consolidated Financial Results for the Nine Months Ended December 31, 2018 （382KB）

• 2019/02/08 Summary of Financial Results for the third quarter 2019 （77KB）

• 2019/02/08 A clinical trial paper on the effects of collagen hydrolysates derived from Tilapia scales or skin on human facial skin was published in Japanese Pharmacology and Therapeutics

  読む A clinical trial paper on the effects of collagen hydrolysates derived from Tilapia scales or skin on human facial skin was published in Japanese Pharmacology and Therapeutics

• 2018/11/20 Notice Concerning Absorption-Type Merger with Wholly-Owned Subsidiary (Simplified Merger and Short-Form Merger) （134KB）

• 2018/11/08 Notice Concerning Recording of Non-Operating Income, Difference between Consolidated Business Forecasts and Actual Results for the Six Months Ended eptember 30, 2018, and Revision of Consolidated Business Forecasts for the Fiscal ear Ending March 31, 2019 （124KB）

• 2018/11/08 Consolidated Financial Results for the Six Months Ended September 30, 2018 （399KB）

• 2018/11/08 Summary of Financial Results for the second quarter 2019 （76KB）

• 2018/08/08 Notice Concerning Recording of Extraordinary Loss (Advisory fees) （39KB）

• 2018/08/08 Notice Concerning Expected Recording of Extraordinary Gain (Progress Report on Disclosed Matters) （107KB）

• 2018/08/08 Consolidated Financial Results for the Three Months Ended June 30, 2018 （347KB）

• 2018/08/08 Summary of Financial Results for the first quarter 2019 （69KB）

• 2018/08/02 A clinical trial paper on the efficacy of Collagen Peptide as add on nutritional supplement in Pressure ulcer was published in Scientific Reports.

• 2018/06/07 A clinical trial paper on the efficacy of Collagen Peptide as add on nutritional supplement in Type 2 Diabetes was published in Journal of Clinical Nutrition and Food Science.

• 2018/05/29 Notice Regarding Resignation of a Member of the Board of Directors （32KB）

• 2018/05/17 Notice Regarding Change in Organization and Executive Officers （127KB）

• 2018/05/17 Notice Concerning Revision of Consolidated Business Forecasts （142KB）

• 2018/05/17 Notice Concerning Board of Directors Resolution regarding the Company Split (Simplified Absorption-Type Split) of the Adhesive Business (Excepting Manufacturing) with Bostik Nitta Co., Ltd. （381KB）

• 2018/05/17 Nitta Gelatin Announces Medium-term Management Plan （247KB）

• 2018/05/10 Consolidated Financial Results for the Fiscal Year Ended March 31, 2018 （614KB）

• 2018/05/10 Notice Concerning Recording of Extraordinary Losses (Impairment Loss on Noncurrent Assets and Loss on Valuation of Shares of Subsidiaries), Differences Between Full-Year Consolidated Financial Forecasts and Results, and Differences Between Non-consolidated Financial Results and Previous Fiscal Year’s Results （193KB）

• 2018/05/10 Summary of Financial Results 2018 （84KB）

• 2018/04/25 Notice of Remembrance Gathering for Seiichi Nitta （29KB）

• 2018/04/02 Bereavement Announcement (Notice of the death of honorary advisor Shinichi Nitta) （31KB）

• 2018/02/08 Consolidated Financial Results for the Nine Months Ended December 31, 2017 （511KB）

• 2018/02/08 Notice Concerning Revision of Consolidated Business Forecasts （118KB）

• 2018/02/08 Summary of Financial Results for the third quarter 2018 （76KB）

• 2017/12/27 A paper on the mechanism of action on the osteoblast differentiation promoting effect of collagen-derived dipeptide Pro-Hyp was published in the International Scientific Journal (Cellular & Molecular Biology Letters).

• 2017/12/20 Our introduction article was published in the science journal "nature [insideview]" December 21, 2017 issue

• 2017/11/08 Consolidated Financial Results for the Six Months Ended September 30, 2017 （432KB）

• 2017/11/08 Summary of Financial Results for the second quarter 2018 （77KB）

• 2017/08/08 Consolidated Financial Results for the Three Months Ended June 30, 2017 （409KB）

• 2017/08/08 Summary of Financial Results for the first quarter 2018 （75KB）

• 2017/06/30 Nitta Gelatin India Ltd. Has Won the “Best Corporate Citizen Award 2017” of Kerala Chapter of National Institute of Personnel Management （171KB）

• 2017/06/01 An article from an interview with President Koichi Ogata was published on Newsweek and The Worldfolio. （206KB）

• 2017/05/10 Notice Concerning Recording of Non-Operating Income and Extraordinary Loss, Differences Between Full-Year Consolidated Financial Forecasts and Results, and Differences Between Non-consolidated Financial Results and Previous Fiscal Year’s Results （246KB）

• 2017/05/10 Consolidated Financial Results for the Fiscal Year Ended March 31, 2017 （827KB）

• 2017/05/10 Summary of Financial Results 2017 （76KB）

• 2017/02/16 Notice Regarding Change in Organization and Personnel （52KB）

• 2017/02/08 Notice Concerning Recording of Non-Operating Income (Foreign Exchange Gains) and Extraordinary Loss (Loss on Retirement of Noncurrent Assets) （111KB）

• 2017/02/08 Consolidated Financial Results for the Nine Months Ended December 31, 2016 （530KB）

• 2017/02/08 Summary of Financial Results for the third quarter 2017 （77KB）

• 2016/11/08 Notice Concerning the Recording of Non-Operating Expenses, Difference Between Consolidated Business Forecasts and Actual Results for the Six Months Ended September 30, 2016, and Revision of Consolidated Business Forecasts for the Fiscal Year Ending March 31, 2017 （85KB）

• 2016/11/08 Consolidated Financial Results for the Six Months Ended September 30, 2016 （588KB）

• 2016/11/08 Summary of Financial Results for the second quarter 2017 （83KB）

• 2016/10/18 Annual Report 2016 （3,888KB）

• 2016/08/08 Notice Concerning Recording of Non-Operating Expense (Foreign Exchange Losses) （108KB）

• 2016/08/08 Consolidated Financial Results for the Three Months Ended June 30, 2016 （361KB）

• 2016/08/08 Summary of Financial Results for the first quarter 2017 （79KB）

• 2016/05/10 Consolidated Financial Results for the Fiscal Year Ended March 31, 2016 （972KB）

• 2016/05/10 Summary of Financial Results 2016 （83KB）

• 2016/04/28 Notice Regarding Change in Appointment of Board Members and Executive Officers （131KB）

• 2016/04/28 Notice Concerning Difference in Non-consolidated Business Forecasts and Previous Fiscal Year’s Results, and the Recording of an Extraordinary Loss (Loss on Valuation of Shares of a Subsidiary) （184KB）

• 2016/04/08 Published in Japan Country Report of South China Morning Post （492KB）

• 2016/02/24 Wellnex collagen peptides show positive outcomes for skin health in RCT and the paper has published on an international journal （Journal of the Science of Food and Agriculture） （105KB）

• 2016/02/18 Notice Regarding Changes in Organization and Personnel （130KB）

• 2016/02/05 Notice Regarding a Change in the Name of a Consolidated Subsidiary （116KB）

• 2016/02/05 Consolidated Financial Results for the Nine Months Ended December 31, 2015 （603KB）

• 2016/02/05 Summary of Financial Results for the third quarter 2016 （77KB）

• 2015/11/26 Our company's history and functionality of our collagen peptide “Wellnex” were introduced in a Chinese TV program“Charming China” broadcasted by China Central Television (CCTV).

• 2015/11/19 Notice Regarding a Change in Organization and Personnel （139KB）

• 2015/11/10 Annual Report 2015 （2,507KB）

• 2015/11/06 Notice Concerning Difference in Consolidated Business Forecasts and Actual Results for the Six Months Ended September 30, 2015 （177KB）

• 2015/11/06 Nitta Gelatin Announces Medium-term Management Plan （239KB）

• 2015/11/06 Consolidated Financial Results for the Six Months Ended September 30, 2015 （644KB）

• 2015/11/06 Summary of Financial Results for the second quarter 2016 （82KB）

• 2015/08/20 Exhibit at 2015 4th TERMIS World Congress （98KB）

• 2015/08/06 Notice Concerning Revision of Consolidated Business Forecasts （203KB）

• 2015/08/06 Consolidated Financial Results for the Three Months Ended June 30, 2015 （611KB）

• 2015/08/06 Summary of Financial Results for the first quarter 2016 （77KB）

• 2015/05/19 Notice Concerning Change in a Consolidated Subsidiary （209KB）

• 2015/05/11 Consolidated Financial Results for the Fiscal Year Ended March 31, 2015 （1,374KB）

• 2015/05/11 Summary of Financial Results 2015 （77KB）

• 2015/04/29 Mr. T. K. A. Nair, former Chairman of Nitta Gelatin India received the Order of the Rising Sun, Gold and Silver Star. （91KB）

• 2015/04/27 Notice Concerning Revision of Consolidated Business Forecasts and Recording of Non-operating Income (Foreign Exchange Gains) for the Fiscal Year Ended March 31, 2015 （203KB）

• 2015/04/24 Notice Regarding Change in Specified Subsidiary （156KB）

• 2015/03/31 Special site of collagen peptides, "Wellnex-Collagen.com" has been launched.

• 2015/02/19 Notice Regarding a Change in Organization and Personnel （144KB）

• 2015/02/06 Notice Concerning Change of Representative Director （168KB）

• 2015/02/06 Consolidated Financial Results for the Nine Months Ended December 31, 2014 （583KB）

• 2015/02/06 Summary of Financial Results for the third quarter 2015 （70KB）

• 2014/11/12 Notice Concerning the Attack at Group Company Nitta Gelatin India Ltd. （90KB）

• 2014/11/06 Consolidated Financial Results for the Six Months Ended September 30, 2014 （331KB）

• 2014/11/06 Notice Concerning Difference in Consolidated Business Forecasts and Results for the Six Months Ended September 30, 2014 and Revision of Consolidated Business Forecasts for the Fiscal Year Ending March 31, 2015 （135KB）

• 2014/11/06 Summary of Financial Results for the second quarter 2015 （73KB）

• 2014/09/29 Annual Report 2014 （2,572KB）

• 2014/08/06 Consolidated Financial Results for the Three Months Ended June 30, 2014 （351KB）

• 2014/05/22 Notice Regarding Partial Correction of Numerical Data in the Consolidated Financial Results for the Fiscal Year Ended March 31, 2014 (Japanese Accounting Standards) for Release as XBRL （84KB）

• 2014/05/16 Financial Results Presentation for the Year Ended March 31,2014 （1,049KB）

• 2014/05/09 Consolidated Financial Results for the Fiscal Year Ended March 31, 2014 （578KB）

• 2014/04/25 Notice Regarding Introduction of Stock Compensation-type Stock Options （103KB）

• 2014/04/25 Notice Regarding Change in Appointment of Board Members and Executive Officers （56KB）

• 2014/02/20 Notice Regarding Change in Organization and Personnel （134KB）

• 2014/02/05 Notice Concerning Revision of Consolidated Business Forecasts （62KB）

• 2014/02/05 Consolidated Financial Results for the Nine Months Ended December 31, 2013 （112KB）

• 2013/11/05 Consolidated Financial Results for the Six Months Ended September 30, 2013 （349KB）

• 2013/10/29 Annual Report 2013 （4,362KB）

• 2013/08/23 Notice of Decision on Number of Shares to be Issued through Third-Party Allotment （95KB）

• 2013/08/08 Consolidated Financial Results for the Three Months Ended June 30, 2013 （114KB）

• 2013/07/22 Notice of Decision on Subscription Price and Offer Price （51KB）

• 2013/07/10 Notice of Issuance of New Shares and Offer of Existing Shares （74KB）

• 2013/05/16 Financial Results Presentation for the Year Ended March 31, 2013 （1,883KB）

• 2013/05/10 Nitta Gelatin Announces Medium-term Management Plan （58KB）

• 2013/05/10 Consolidated Financial Results for the Fiscal Year Ended March 31, 2013 （211KB）

• 2013/04/26 Notice Regarding Change in Statutory Auditor,Executive Officers and Other Personnel （46KB）

• 2013/04/01 Nitta Gelatin Inc. will participate in ifia Japan 2013 （40KB）

• 2013/02/21 Notice Regarding Completion of Procedures for Establishment of a Joint Venture Company in Vietnam (Follow-up Disclosure) （44KB）

• 2013/02/21 Notice Regarding Change in Organization and Personnel （50KB）

• 2013/02/08 Notice Regarding Year-end Dividend Forecast Revision (Commemorative Dividend for Listing on the First Section of the Tokyo Stock Exchange) for the Year Ending March 31, 2013 （46KB）

• 2013/02/08 Consolidated Financial Results for the Nine Months Ended December 31, 2012 （155KB）

• 2012/12/13 Nitta Gelatin Approved for Listing on the First Section of the Tokyo Stock Exchange （26KB）

• 2012/11/09 Consolidated Financial Results for the Six Months Ended September 30, 2012 （157KB）

• 2012/10/17 Notice Regarding Establishment of Joint Venture Company in Vietnam （49KB）

• 2012/09/28 Notice Regarding the Completion of Procedures for the Establishment of a Joint Venture in China （28KB）

• 2012/09/28 Annual Report 2012 （1,231KB）

• 2012/08/09 Consolidated Financial Results for the Three Months Ended June 30, 2012 （90KB）

• 2012/06/27 Notice Regarding Establishment of Joint Venture and Changes in Specified Subsidiaries （31KB）

• 2012/05/11 Consolidated Financial Results for the Fiscal Year Ended March 31, 2012 （386KB）

• 2012/04/27 Notice Regarding the Appointment of a Substitute Statutory Auditor （29KB）

• 2012/03/21 Notice Regarding Change in Organization and Personnel （61KB）

• 2012/03/21 Notice Regarding Joint Venture in China （30KB）

• 2012/03/02 Notice Regarding Selection as Loanable Stock （27KB）

• 2012/02/09 Consolidated Financial Results for the Nine Months Ended December 31, 2011 （154KB）

• 2012/02/09 Notice Regarding the Establishment of a Shareholder Benefit Program （104KB）

• 2012/01/13 Notice Regarding Results of Capital Increase Through Third-Party Allotment （22KB）

• 2011/12/20 Financial Results and Other Information Accompanying the Listing of Nitta Gelatin on the Second Section of the Tokyo Stock Exchange （120KB）

• 2011/12/12 Notice Regarding Decision on the Price for the Subscription and Placement of Shares to the Public, and on the Number of Existing Shares Offered to Cover Over-allotments （45KB）

• 2011/12/02 Notice of Board of Directors Resolution Concerning the Amount to Be Paid In, and the Provisional Issuance Terms for Book-Building,on the Placement of Shares for Public Subscription （39KB）

• 2011/11/16 Notice of Board of Directors Resolution Concerning Issuance of New Shares, Disposal of Treasury Stock and Offer of Existing Shares （76KB）

• 2011/11/15 Nitta Gelatin Approved for Listing on the Second Section of the Tokyo Stock Exchange （35KB）